Silver Point Capital, based in Greenwich, Connecticut, is a global credit investment firm specializing in credit and special situations investments. Founded with a focus on navigating credit markets across cycles, the firm employs a multi-strategy approach to capitalize on opportunities in various credit sectors. Silver Point's investment philosophy is rooted in disciplined risk management and a unified credit platform.
Led by founders Ed Mulé and Bob O'Shea, Silver Point Capital has built a team of over 100 employees, leveraging deep resources and expertise to execute their investment strategy. The firm has made notable investments in companies such as PatientPoint and Xanodyne Pharmaceuticals, demonstrating their ability to identify and support promising opportunities in diverse industries.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
